Mol Psychiat:新研究发现血液测试或可预测自杀倾向

2015-08-21 sunshine 译 MedSci原创

Molecular Psychiatry:新研究发现血液测试或可预测自杀倾向 近日,来自印第安纳大学医学院的一项新的研究表明,血液测试结合问卷调查或可预测一个人的自杀倾向,且其准确度可达90%,该研究成果发表于《分子精神病学》。研究人员表示,他们已经开发出一种可在病人血液中找到11个生物标志物的简单的测试,将此测试与以应用程序为基础的调查问卷结合时,便可在已接受精神治疗的患者中

近日,来自印第安纳大学医学院的一项新的研究表明,血液测试结合问卷调查或可预测一个人的自杀倾向,且其准确度可达90%,该研究成果发表于《分子精神病学》。
研究人员表示,他们已经开发出一种可在病人血液中找到11个生物标志物的简单的测试,将此测试与以应用程序为基础的调查问卷结合时,便可在已接受精神治疗的患者中预测出谁将会在治疗后两年内仍可产生自杀的念头。


“我们相信,基于健康评估时的这些发现的危险预测测试的广泛采用使得临床医生能够通过干预患者的生活方式或治疗来挽救患者的生命,”共同作者 Alexander B. Niculescu III教授说道。
由于本研究的样本量太小,仅纳入了200名男性加以研究分析,因而并不是所有的科学家认同这一发现。样本量太小意味着在考虑分析比较罕见的条件时得出的结果容易产生偏差。

另一个问题是,如果将这样的测试广泛应用于大众,那么一些假阳性的结果(结果显示某些人可能会自杀,而这些人本身并无自杀的念头)可能会很高。再加上许多不同的环境以及行为因素可增加个体自杀的风险,因此这些结果发现仍不能让很多人信服。

尽管此研究备受争议,但是研究人员仍然对使用生物标志物预测心理健康表现出越来越大的兴趣。就在去年类似的研究表明SKA2基因可用于预测自杀风险,尽管此结论被批判过于简单化。本次新的研究着眼于寻找更广泛的生物标志物并追踪它们在患者精神紊乱(从精神分裂到阿尔茨海默症)接受治疗的几年内其水平的变化情况。此外,它们还分析了26名自杀患者的血液样本。

近年来,很多国家的自杀率都在上升。目前,自杀是导致英国35岁以下男性死亡的一个主要原因,在美国也已达到了历史新高——每12.8分钟便有一人自杀。使得自杀成为了一个非常现实的问题,急需更好的系统加以预测。
 
原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
    2015-12-04 lyh994

    什么标记物?

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
    2015-10-25 三三五五

    感谢!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
    2015-10-12 hlycom3356

    这篇文章写的很好

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
    2015-10-12 hlycom3356

    这篇文章写的很好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
    2015-10-11 hlycom3356

    感谢作者分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1753114, encodeId=30e01e53114c5, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Wed Jul 13 03:03:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951113, encodeId=58861951113b2, content=<a href='/topic/show?id=580a89302c6' target=_blank style='color:#2F92EE;'>#血液测试#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89302, encryptionId=580a89302c6, topicName=血液测试)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e12a151, createdName=yangeasy, createdTime=Mon Sep 07 01:03:00 CST 2015, time=2015-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44790, encodeId=ca4d44e90d6, content=什么标记物?, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Dec 04 22:02:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41069, encodeId=de4b41069d3, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df9e1651052, createdName=三三五五, createdTime=Sun Oct 25 14:12:00 CST 2015, time=2015-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38663, encodeId=b73e38663b5, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38664, encodeId=fd06386645e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:53:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38381, encodeId=5fd23838144, content=感谢作者分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Sun Oct 11 21:02:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35998, encodeId=68a13599881, content=吼吼, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5iaecibYX9C8bibtETqRvxVQNud0LKVXWwpDY3GzJtHxWqTE33oKEBhoVuYmicqyt9EKbP8vuW5TkINg/0, createdBy=d3331644082, createdName=nina1125, createdTime=Sun Aug 23 13:33:00 CST 2015, time=2015-08-23, status=1, ipAttribution=)]
    2015-08-23 nina1125

    吼吼

    0

相关资讯

PLOS ONE:新型血液测试快速诊断细菌病毒 可少吃消炎药

近日,BBC发文称,Plos One上的一篇研究认为,一个新的血液诊断测试可以帮助医生在2h内找出病人是因病毒还是细菌感染,科学家认为,这项研究将使患者免受不必要的抗生素。 尽管研究目前仍处于实验室研究阶段,但这个团队的科学家已经开始在研究便携式的有关设备。那些没有参与这项研究的其他专家认为这项研究成果解决了一个难题。科学家已经开始在进行更加深入的研究。 该方法促使医生使用恰当的药物 当医生

JASN:新的血液测试检测致命性钙沉积

一种新的测试方法可以帮助鉴定和治疗那些组织和血管中可能会出现潜在致命性钙沉积在风险的患者,据一项发表在Journal of the American Society of Nephrology杂志上的研究表明。心脏疾病是慢性肾脏病(CKD)患者的头号杀手,血管钙化被认为在此种疾病中发挥了重要作用。 慢性肾脏病患者血液中往往具有异常高水平的钙,原因是由于患者自身肾功能受损以及使用药物的影响。过量钙

AJG:简单的血液测试就可帮助诊断胰腺癌

近日,来自印第安纳大学的癌症研究人员研究发现,一种简单的血液检测或许可以帮助诊断胰腺癌,相关研究成果刊登于国际杂志the American Journal of Gastroenterology上。 研究者Myles Brand教授表示,胰腺癌是致死率最高的一种癌症,本文中我们发现了一些microRNAs在胰腺癌患者的血液中的循环水平较高,因此通过对血液中循环的microRNAs分子水平的测

英研究称简单血液测试可检测乳腺癌

据法国《观点报》6月30日报道,英国研究发现,一个简单的血液测试可预先10年发现是否患有乳腺癌。 报道称,一个简单的血液测试或许就可以挽救许多人的生命。法国国家健康与医学研究院指出,尽管近14年来,乳腺癌患者死亡率有所下降,但2010年,仍有1.15万名女性死于乳腺癌。不过,伦敦大学学院研究人员在《基因组医学》杂志中发表的科学研究成果或将大大降低这一数字。据研究人员称,一个简单的血液测试即可预先